Study on the effect of Fluconazole on the pharmacokinetics of Imrecoxib Tablets in healthy subjects (Single-centre, Single-arm, Open, Self-control)

Trial Profile

Study on the effect of Fluconazole on the pharmacokinetics of Imrecoxib Tablets in healthy subjects (Single-centre, Single-arm, Open, Self-control)

Recruiting
Phase of Trial: Phase I

Latest Information Update: 26 Apr 2016

At a glance

  • Drugs Imrecoxib (Primary) ; Celecoxib; Fluconazole
  • Indications Inflammation; Osteoarthritis
  • Focus Pharmacokinetics
  • Sponsors Jiangsu Hengrui Medicine Co.
  • Most Recent Events

    • 26 Apr 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top